Membrane-targeted antibiotic for the treatment of skin and lung infections caused by drug resistant pathogens including MRSA, VISA, VRE and S pneumoniae (2011–2015)

Grant type:
Wellcome Trust Seeding Drug Discovery
Researchers:
Funded by:
The Wellcome Trust